Endothelial safety of radiological contrast media: Why being concerned

详细信息    查看全文

• 作者：Egeria Scoditti^a ; ^{egeria.scoditti@ifc.cnr.it} ; Marika Massaro^a ; Maria Rosa Montinari^b
• 关键词：Endothelial cells ; Iodinated contrast media ; Inflammation ; Oxidative stress ; Apoptosis ; Endothelium-derived factors
• 刊名：Vascular Pharmacology
• 出版年：2013
• 出版时间：January-February, 2013
• 年：2013
• 卷：58
• 期：1-2
• 页码：48-53
• 全文大小：410 K

文摘

Iodinated radiocontrast media have been the most widely used pharmaceuticals for intravascular administration in diagnostic and interventional angiographic procedures. Although they are regarded as relatively safe drugs and vascular biocompatibility of contrast media has been progressively improved, severe adverse reactions may occur, among which acute nephropathy is one of the most clinically significant complications after intravascular administration of contrast media and a powerful predictor of poor early and long-term outcomes. Since radiocontrast media are given through the arterial or the venous circulation in vascular procedures, morphological and functional changes of the microvascular and macrovascular endothelial cells substantially contribute to the pathogenesis of organ-specific and systemic adverse reactions of contrast media. Endothelial toxicity of contrast media seems to be the result of both direct proapoptotic effects and morphological derangements, as well as endothelial dysfunction and induction of inflammation, oxidative stress, thrombosis, and altered vasomotor balance, with predominant vasoconstrictive response in atherosclerotic coronary arteries and kidney microcirculation. Further understanding of pathogenetic mechanisms underlying contrast media-induced adverse reactions in cellular targets, including endothelial cells, will hopefully lead to the development of novel preventive strategies appropriately curbing the pathogenesis of contrast media vasotoxicity.